139
Green light from the FDA to use the Pfizer-BioNTech vaccine on children between the ages of 5 and 11. “The authorization – reads the website of the Food and Drug Administration – is based on the in-depth and transparent evaluation of the data by the FDA, which includes the contribution of experts from the independent advisory committee who voted overwhelmingly in favor of making the data available. vaccine for children of this age group “.
The Pfizer vaccine will be given to children in two doses, 3 weeks apart, but this will be a lower dose (10 micrograms) than that used for individuals 12 years and older (30 micrograms).